Previous 10 | Next 10 |
Endo International plc (ENDP) Q4 2021 Earnings Conference Call March 01, 2022 07:30 AM ET Company Participants Laure Park - Senior Vice President, Investor Relations and Corporate Affairs Blaise Coleman - President and CEO Mark Bradley - Executive Vice President and CFO Patrick Barry - Presid...
Gainers: CTI BioPharma (NASDAQ:CTIC) +40%. Oak Street Health (NYSE:OSH) +23%. AVITA Medical (NASDAQ:RCEL) +15%. Axsome Therapeutics (NASDAQ:AXSM) +14%. Protagonist Therapeutics (NASDAQ:PTGX) +12%. Losers: GoodRx Holdings (NASDAQ:GDRX) -40%. Semler Scientific...
Endo International (NASDAQ:ENDP) was stripped of its legal defenses in an upcoming trial in Tennessee over the company’s role in the opioid crisis, Bloomberg reported on Tuesday. The decision taken by Judge Jonathan Lee Young of Tennessee Circuit Court was due to Endo...
The following slide deck was published by Endo International plc in conjunction with their 2021 Q4 earnings call. For further details see: Endo International plc 2021 Q4 - Results - Earnings Call Presentation
Endo International (NASDAQ:ENDP) shares are down 6% in after-hours trading despite reporting Q4 2021 earnings results that beat on the top and bottom lines. Non-GAAP EPS of $0.84 in Q4 2021 was an improvement from the $0.84 seen in Q4 2020, Revenue increased 4% in the quarter to $78...
Endo press release (NASDAQ:ENDP): Q4 Non-GAAP EPS of $0.84 beats by $0.16. Revenue of $784.4M (+3.2% Y/Y) beats by $50.43M. Shares -1%. 1Q22 guidance: Revenues: $595B - $635B; non-GAAP EPS: $0.35- $0.45; non-GAAP EBITDA: $240M-$260M. For further details see: Endo Non-GAAP...
ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS Canada NewsWire DUBLIN , Feb. 28, 2022 /CNW/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and intr...
ACAD,ACHC,AGM,AMBA,AMRC,OTCPK:AOIFF,APLS,APPF,APTS,ARCT,ARDX,ASXC,ATRA,AVIR,AY,BANX,BIGC,BLFS,BLNK,BRMK,CAPL,CLDX,CO,CSR,CSTL,DAR,DDD,DNMR,DVAX,ENDP,EVA,FATE,FGEN,FRPT,FSK,GAIA,GDRX,GMRE,GOEV,GPOR,GRPN,HHC,HPQ,HRTX,ICAD,KD,LAZR,LCID,MBI,MDXG,MRTX,NKTR,NMFC,NVAX,NVEE,OCUL,OKE,ONTF,OTIC,PDCE,PG...
Endo (NASDAQ:ENDP) is scheduled to announce Q4 earnings results on Monday, Feb. 28, after market close. The consensus EPS estimate is $0.68 (-9.3% Y/Y) and the consensus revenue estimate is $733.97M (-3.5% Y/Y). Over the last 2 years, ENDP has beaten EPS estimates 100% of the time and has bea...
Endo International (NASDAQ:ENDP) said it expects a Tennessee state court to grant a default judgment against it in regards to the company's sale of prescription opioids. Endo is a defendant in Dunaway, et al. v. Purdue Pharma, L.P., et al., which is pending in the Circuit Court for Cumberland...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...